Nuvation Bio (NUVB) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed Nuvation Bio (NUVB) over the past year, losing 20.0% versus a loss of 45.6%. Over five years, PAHC leads with a +59.4% price change compared with -53.5% for NUVB. Phibro Animal Health is the larger company by market cap ($1.35 billion vs $1.34 billion), about 1.0 times the size, while Nuvation Bio is growing revenue faster (+699.0% vs +17.1%).
Phibro Animal Health pays a dividend yielding 1.44%, while Nuvation Bio does not currently pay one. Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -325.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUVB | PAHC |
|---|---|---|
| Share price | $3.80 | $33.29 |
| Market cap | $1.34B | $1.35B |
| 1-day change | -0.26% | -2.32% |
| YTD return | -57.59% | -10.89% |
| 1-year return | -45.64% | -20.03% |
| 5-year return | -53.49% | +59.43% |
| P/E ratio (TTM) | — | 13.26 |
| Forward P/E | — | 8.58 |
| EPS (TTM) | $-0.39 | $2.51 |
| Dividend yield | 0.00% | 1.44% |
| Annual dividend | $0.00 | $0.48 |
| Revenue (latest FY) | $62.90M | $1.52B |
| Revenue growth (YoY) | +698.96% | +17.12% |
| Net income (latest FY) | $-204.63M | $99.72M |
| Gross margin | — | 33.76% |
| Operating margin | -338.72% | 12.81% |
| Net margin | -325.31% | 6.57% |
| 52-week high | $9.75 | $60.08 |
| 52-week low | $3.71 | $28.25 |
| Distance from 52-week high | -61.03% | -44.59% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +227.63% | +41.18% |
| Average volume | 5.24M | 228.99K |
| Shares outstanding | 352.02M | 21.11M |
| Employees | 310 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PAHC has outperformed NUVB by 25.6 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.44% vs 0.00%).
- Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -325.3 cents for Nuvation Bio.
- Nuvation Bio grew revenue faster in its latest fiscal year (+698.96% vs +17.12%).
About Nuvation Bio
NUVB stock →Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 310 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
NUVB vs PAHC FAQ
Which is bigger, Nuvation Bio or Phibro Animal Health?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.35B compared with $1.34B for Nuvation Bio (NUVB).
Which stock has performed better over the past year, NUVB or PAHC?
PAHC returned -20.03% over the past 12 months, compared with -45.64% for NUVB (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Nuvation Bio or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.44%, while Nuvation Bio does not currently pay a regular dividend.
Are Nuvation Bio and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.